Etamsylate
![Hemostatical Activity of New Benzylammonium Salt 2-[3-Methyl-1-N- Propyl-7-(1,1-Dioxotiethanyl-3)Xantinyl-8-Thio]Acetic Acid](http://data.docslib.org/img/264x/2a9c2d1e3aec1d4baeade8bf45a38ad6.webp)
Top View
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- MFT Formulary V7.9 (June 2021) MFT TRUST FORMULARY
- Two Cases of Anaphylaxis to Tranexamic Acid Confirmed
- (12) United States Patent (10) Patent No.: US 6,939,559 B1 Nishibe Et Al
- Guidelines on the Management of Bleeding for Palliative Care Patients with Cancer - Summary
- Tranexamic Acid and Ethamsylate for Reducing Blood Loss in Patient Undergoing Lower Segment Cesarean Section at High Risk for Post-Partum Hemorrhage: a Pilot Study
- A Comparative Study of Tranexamic Acid and Ehamsylate for Control of Blood Loss Key Words: in Functional Endoscopic Sinus Surgery
- Product List
- Atc Index 2010
- Prospective Randomised Comparative Study Of
- Klasifikacija ATC 2019
- Synthesis of a Series of Benzothiazole Amide Derivatives and Their Biological Evaluation As Potent Cite This: RSC Adv.,2018,8,6231 Hemostatic Agents†
- Acquired Hemophilia a As a Cause of Recurrent Bleeding Into the Pleural Cavity – Case Report and Literature Review
- Medicines Formulary
- Analytical Methods for the Determination of Thrombolytics
- Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags?
- Annexes to the Annual Report of the European Medicines Agency 2018
- 2015 Report on Prohibited Substances